Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: Mutat Res. 2005 Oct 3;586(2):160–172. doi: 10.1016/j.mrgentox.2005.06.002

Table 1.

Cytotoxicity and clastogenicity of lead chromatea

Treatment (μg/cm2 LC) Relative survival (% of control) Percent of metaphases with damageb,c Total damage in 100 metaphasesb,c Percent of apoptosis
0d 100 2 ±0.4 2 ±0.4 2.9 ±0.5
0.1 83 9 ±1.1e 9 ±1.2e 3.3 ±0.2
0.5 66 23 ±2.9e 27 ±4.2e 4.1 ±0.7
1.0 56 34 ±1.9e 42 ±3.0e 4.2 ±0.2
5.0 8 NMf NM 6.8 ±0.7
a

Average of three experiments.

b

±Standard error of the mean.

c

Average of five experiments.

d

0: vehicle control (acetone).

e

Significantly (p < 0.001) different compared to vehicle control.

f

NM: no metaphases.